HAIFA, Israel, Feb. 18 /PRNewswire/ -- Elscint Ltd. (NYSE: ELT), a
subsidiary of Elbit Medical Imaging Ltd. (Nasdaq: EMITF), announced that it
has received a proposal from Elbit Medical Imaging Ltd. for a business
combination, pursuant to which the public shareholders of Elscint would
receive $14.00 per share in cash. This proposal is for approximately
7,012,967 Elscint shares (or approximately 43% of the outstanding shares) not
currently owned by Elbit Medical Imaging Ltd.
This proposal will be considered by the Board of Directors of Elscint.
This release contains certain forward-looking statements which involve
known and unknown risks, uncertainties or other factors not under the
Company's control which may cause actual results, performance or achievements
of the Company to be materially different from the results, performance or
other expectations implied by these forward-looking statements. These factors
include, but are not limited to, those detailed in the Company's periodic
filings with the Securities and Exchange Commission.
SOURCE Elscint Ltd.
 back to top
Related links:
http://www.elscint.co.il
CONTACT:
Gabi Yankovitz, VP, Finance & CFO of Elscint
Ltd., 972-4-8310271; or General Info., Laurie Berman,
310-442-0599, or Media Info., Alicia Nieva-Woodgate,
415-986-1591, or Investor Info., Brian Gill, 212-661-8030, all of
The Financial Relations Board
NOTE TO EDITORS: For further information on Elscint, via
facsimile at no cost, please call 800-PRO-INFO and enter company
code 206 or ticker symbol ELT.
|
